Table: begin end state 1 31 cytoplasmic 32 52 transmembrane 53 63 non-cytoplasmic 64 87 transmembrane 88 98 cytoplasmic 99 118 transmembrane 119 122 non-cytoplasmic 123 147 transmembrane 148 166 cytoplasmic 167 187 transmembrane 188 198 non-cytoplasmic 199 218 transmembrane 219 260 cytoplasmic 261 279 transmembrane 280 298 non-cytoplasmic 299 319 transmembrane 320 327 cytoplasmic 328 347 transmembrane 348 352 non-cytoplasmic 353 377 transmembrane 378 388 cytoplasmic 389 412 transmembrane 413 417 non-cytoplasmic 418 439 transmembrane 440 500 cytoplasmic
Input: >PP_2914 MKPRKKSVQPIGLKDITIVDDAKMKKAITAAALGNAMEWFDFGVYGFVAYALGKVFFPNA DPSVQMIAALATFSVPFLIRPLGGLFFGALGDRFGRQKILAATIVIMSLSTFAIGLIPSY ASIGIWAPILLLLAKMAQGFSVGGEYTGASIFVAEYAPDRKRGFLGSWLDFGSIAGFVLG AGVVVLISTVLGEEKFLDWGWRLPFFLALPLGIIGLYLRHALEETPAFQQHVDKLEQGDR EGLASGPKVSFKEVATQHWRSLVTCIGVVIATNVTYYMLLTYMPSYLSHNLHYSEDHGVL IIIAIMVGMLFVQPIIGLLSDKFGRRPFIIVGSVGLLALAIPAFMLINSGVLGLIFAGLL IIAVLLNFFIGVMASTLPAMFPTHIRYSALASAFNISVLIAGLTPTLAAWLVETTNDLYM PAYYLMVIAAVGLVTGLTMKETANKPLRGAAPAASDIEEARELLQEHHDNIEQKIEDIDA QIAELEAKREKLALQHPRIE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server